Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus conventional chemotherapy

Leukemia, Published online: 26 March 2024; doi:10.1038/s41375-024-02208-8Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus conventional chemotherapy

https://www.nature.com/articles/s41375-024-02208-8

Source: Leukemia - March 26, 2024 Category: Hematology Authors: Eduardo Sabino de Camargo Magalh ães Stefan Edward Hubner Brandon Douglas Brown Yihua Qiu Steven Mitchell Kornblau Source Type: research

More News: Acute Leukemia | Acute Myeloid Leukemia | Chemotherapy | Hematology | Leukemia